Recursion Pharmaceuticals has a flashy drug development platform. It has a lot to prove about whether that platform's use of AI is helpful. Some power players have backed it with significant ...

Then eventually that royalty stack starts to add up and it's cutting into your profitability long term.” In the companies’ “Learnings call” explaining the merger, Recursion CEO Chris ...

Claude, v0, etc are incredible- but you can't install packages, run backends or edit code. That’s where Bolt.new stands out: Full-Stack in the Browser: Bolt.new integrates cutting-edge AI models with ...

After hours: January 17 at 7:59:34 p.m. EST ...